Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Dana Carroll, PhD
Department of Biochemistry
University of Utah
15 N Medical Drive East, Room: 4100
Salt Lake City, Utah, United States
Dana Carroll, PhD, is a distinguished professor in the Department of Biochemistry at the University of Utah School of Medicine and a member of the Nuclear Control of Cell Growth and Differentiation Program at the Huntsman Cancer Institute. Carroll’s research involves making specific changes in chromosomal DNA using targetable nucleases. His lab pioneered the development of zinc-finger nucleases as gene targeting tools, and they have continued working with the more recent TALENs and CRISPR/Cas nucleases. Much of the effort has been focused on optimizing the efficiency of these reagents for targeted mutagenesis and gene replacement, which could ultimately provide treatment for many diseases, including sickle cell disease. This technology has now been applied to more than 40 different organisms, including current clinical trials in humans.
Dental Health in Children with Sickle Cell DiseaseWhat is Sickle Cell Disease? Sickle Cel...
Amber Yates, MDDr. Amber Yates is an Associate Director...
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
Johnson Haynes, MDJohnson Haynes is the Director at Compre...
Fondation Pierre FabreRecognized as a public utility since 199...
The Sickle Cell Infusion Center at Johns HopkinsThe Sickle Cell Center for Adults is ded...